Business Wire
Business$10,000 in Apple: a Yahoo Finance-linked projection targets long-range value by 2031The Apex TimesBusinessBerkshire Hathaway buying streak after an IPO puts Greg Abel’s leadership style in focusThe Apex TimesBusinessCostco shares regain key technical levels as September sales momentum lifts compsThe Apex TimesBusinessApple shares hit a record close before its Nov. 2 report as attention turns to whether paid upgrades for Siri AI could change the earnings outlookThe Apex TimesBusinessTesla’s self-driving lawsuit setback: appeals court rules buyers can’t sue as a classThe Apex TimesBusinessBoeing’s Sales Chief Plans to Retire, as the Plan to Convert $27.5 Billion in Built-Up Jet Costs Into Cash Takes Center StageThe Apex TimesBusinessEli Lilly’s weight-loss drug draws renewed attention as an EU regulator move sets up a key Oct. 29 catalystThe Apex TimesBusinessApple’s $1,999 Foldable iPhone Sells Out Quickly as Delivery Timeline Slips Into January, Report SaysThe Apex TimesBusinessLockheed Martin’s reported $230 Billion Backlog Puts a Spotlight on Defense Revenue VisibilityThe Apex TimesBusinessApple and Nvidia each reportedly gave $25 million to Trump’s White House ballroom, but the president’s name does not appear on the donor listThe Apex TimesBusinessMartin Shkreli Touts Photonic Chips as a Potential Threat to Nvidia’s AI DominanceThe Apex TimesBusinessPalantir investors wrestle with retail profit-taking as Wall Street sets up a potential next catalystThe Apex TimesBusiness$10,000 in Apple: a Yahoo Finance-linked projection targets long-range value by 2031The Apex TimesBusinessBerkshire Hathaway buying streak after an IPO puts Greg Abel’s leadership style in focusThe Apex TimesBusinessCostco shares regain key technical levels as September sales momentum lifts compsThe Apex TimesBusinessApple shares hit a record close before its Nov. 2 report as attention turns to whether paid upgrades for Siri AI could change the earnings outlookThe Apex TimesBusinessTesla’s self-driving lawsuit setback: appeals court rules buyers can’t sue as a classThe Apex TimesBusinessBoeing’s Sales Chief Plans to Retire, as the Plan to Convert $27.5 Billion in Built-Up Jet Costs Into Cash Takes Center StageThe Apex TimesBusinessEli Lilly’s weight-loss drug draws renewed attention as an EU regulator move sets up a key Oct. 29 catalystThe Apex TimesBusinessApple’s $1,999 Foldable iPhone Sells Out Quickly as Delivery Timeline Slips Into January, Report SaysThe Apex TimesBusinessLockheed Martin’s reported $230 Billion Backlog Puts a Spotlight on Defense Revenue VisibilityThe Apex TimesBusinessApple and Nvidia each reportedly gave $25 million to Trump’s White House ballroom, but the president’s name does not appear on the donor listThe Apex TimesBusinessMartin Shkreli Touts Photonic Chips as a Potential Threat to Nvidia’s AI DominanceThe Apex TimesBusinessPalantir investors wrestle with retail profit-taking as Wall Street sets up a potential next catalystThe Apex TimesBusiness$10,000 in Apple: a Yahoo Finance-linked projection targets long-range value by 2031The Apex TimesBusinessBerkshire Hathaway buying streak after an IPO puts Greg Abel’s leadership style in focusThe Apex TimesBusinessCostco shares regain key technical levels as September sales momentum lifts compsThe Apex TimesBusinessApple shares hit a record close before its Nov. 2 report as attention turns to whether paid upgrades for Siri AI could change the earnings outlookThe Apex TimesBusinessTesla’s self-driving lawsuit setback: appeals court rules buyers can’t sue as a classThe Apex TimesBusinessBoeing’s Sales Chief Plans to Retire, as the Plan to Convert $27.5 Billion in Built-Up Jet Costs Into Cash Takes Center StageThe Apex TimesBusinessEli Lilly’s weight-loss drug draws renewed attention as an EU regulator move sets up a key Oct. 29 catalystThe Apex TimesBusinessApple’s $1,999 Foldable iPhone Sells Out Quickly as Delivery Timeline Slips Into January, Report SaysThe Apex TimesBusinessLockheed Martin’s reported $230 Billion Backlog Puts a Spotlight on Defense Revenue VisibilityThe Apex TimesBusinessApple and Nvidia each reportedly gave $25 million to Trump’s White House ballroom, but the president’s name does not appear on the donor listThe Apex TimesBusinessMartin Shkreli Touts Photonic Chips as a Potential Threat to Nvidia’s AI DominanceThe Apex TimesBusinessPalantir investors wrestle with retail profit-taking as Wall Street sets up a potential next catalystThe Apex TimesBusiness$10,000 in Apple: a Yahoo Finance-linked projection targets long-range value by 2031The Apex TimesBusinessBerkshire Hathaway buying streak after an IPO puts Greg Abel’s leadership style in focusThe Apex TimesBusinessCostco shares regain key technical levels as September sales momentum lifts compsThe Apex TimesBusinessApple shares hit a record close before its Nov. 2 report as attention turns to whether paid upgrades for Siri AI could change the earnings outlookThe Apex TimesBusinessTesla’s self-driving lawsuit setback: appeals court rules buyers can’t sue as a classThe Apex TimesBusinessBoeing’s Sales Chief Plans to Retire, as the Plan to Convert $27.5 Billion in Built-Up Jet Costs Into Cash Takes Center StageThe Apex TimesBusinessEli Lilly’s weight-loss drug draws renewed attention as an EU regulator move sets up a key Oct. 29 catalystThe Apex TimesBusinessApple’s $1,999 Foldable iPhone Sells Out Quickly as Delivery Timeline Slips Into January, Report SaysThe Apex TimesBusinessLockheed Martin’s reported $230 Billion Backlog Puts a Spotlight on Defense Revenue VisibilityThe Apex TimesBusinessApple and Nvidia each reportedly gave $25 million to Trump’s White House ballroom, but the president’s name does not appear on the donor listThe Apex TimesBusinessMartin Shkreli Touts Photonic Chips as a Potential Threat to Nvidia’s AI DominanceThe Apex TimesBusinessPalantir investors wrestle with retail profit-taking as Wall Street sets up a potential next catalystThe Apex Times
Back to front
Johnson & Johnson set to report second-quarter results Tuesday, with Wall Street looking for higher earnings per share
The Apex Times

THE APEX TIMES

Business/The Apex Times/Jul 15, 8:10 AM EDT

Johnson & Johnson set to report second-quarter results Tuesday, with Wall Street looking for higher earnings per share

Ahead of the opening bell on Wednesday, July 15, analysts are looking for Johnson & Johnson to post quarterly earnings of $2.85 per share, compared with $2.77 per share a year earlier. A Yahoo Finance piece also framed the event as an opportunity for income-seeking investors, though it did not provide details in the information available here.

Johnson & Johnson is scheduled to release its second-quarter earnings report before the opening bell on Wednesday, July 15, according to a market note published by Yahoo Finance. The company’s upcoming results are expected to be closely watched by investors trying to gauge whether the company’s performance is holding up heading into the middle of the year.

In the Yahoo Finance report, analysts are expected to show quarterly earnings per share (EPS) of $2.85. That would represent an increase from $2.77 per share reported in the same quarter a year earlier, suggesting modest year-over-year improvement that could influence near-term sentiment around the stock.

The Yahoo Finance story’s headline leaned into a personal-finance framing, describing a way to “earn $500 a month” from Johnson & Johnson shares ahead of earnings. However, based on the available excerpted information, the specific mechanics of that “$500 a month” approach (for example, whether it relies on dividends, option income, or another strategy) are not detailed here, and those details would need to be verified in the full article.

Because the report is positioned as market news rather than a company filing, it does not itself add new operating disclosures about Johnson & Johnson’s business. Instead, it points to the timing of the earnings event and the consensus EPS expectation, both of which can shape how trading activity evolves in the days leading up to the release.

Johnson & Johnson, a large-cap healthcare company, is widely followed partly because its results often act as a barometer for broader demand trends in pharmaceuticals and medical devices. When consensus expectations shift, even modestly, it can affect how investors price the company’s earnings power heading into the next quarter.

For investors, the pre-earnings window typically serves as a referendum on whether the company can meet or beat expectations, and whether any guidance or commentary changes the outlook. With EPS expectations indicating growth from the prior year, the key question for the market will be whether the company’s actual results and any commentary align with that trajectory.

What is not available in the information provided is any breakdown of revenue, segment performance, guidance, or management commentary. In addition, the Yahoo Finance excerpt does not disclose whether the “income” framing is tied specifically to the dividend, share repurchases, or derivative strategies, so readers should treat the “$500 a month” framing as a claim that depends on the omitted details of the underlying method.

Going into the print, the most actionable items to watch are the reported quarterly EPS versus the $2.85 expectation referenced in the note, and what management says about demand and margins. Any variance from consensus, especially if it comes with updated outlook language, is likely to drive stock movement once the report is released.

Why It Matters

  • Pre-earnings expectations around EPS can strongly influence how investors position ahead of the release.
  • A year-over-year EPS increase, even if modest, can affect perceived earnings momentum across healthcare large caps.
  • Income-oriented market narratives often drive additional trading activity around earnings, but the underlying strategy details are crucial to evaluate.
  • The first reaction in the stock is likely to hinge on whether results track the cited $2.85 consensus number and what management indicates about the next quarter.

Sources

Key Facts

  • Johnson & Johnson is expected to release its second-quarter earnings report before the opening bell on Wednesday, July 15.
  • The Yahoo Finance market note cites an analyst consensus EPS expectation of $2.85 for the quarter.
  • That $2.85 figure is compared with $2.77 EPS from the same quarter a year earlier.
  • The Yahoo Finance headline frames the period before earnings as a way to generate income from the stock, but the specific method is not provided in the excerpted information here.

Healthcare Related

Johnson & Johnson set to report second-quarter results Tuesday, with Wall Street looking for higher earnings per share | The Apex Times